FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 04
Essaar Inc. Issues Voluntary Nationwide Recall of Rubbing Alcohol Contaminated with Methanol
Drugs
Dec 31
Divvies, LLC Issues Allergy Alert on Undeclared Milk and Eggs in Vanilla Cupcakes
Food & Beverages
Dec 31
Precision Dose, Inc. Issues Voluntary Nationwide Recall of Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12%, 15mL Due to Microbial Contamination
Drugs
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
The FDA Food Safety Modernization Act at 10: Reflecting on Our Progress and the Path Forward
For 10 years, dedicated teams of FDA experts, as well as many stakeholders, have been working to implement FSMA.
2020 at FDA: A Year of Unparalleled Contributions to Public Health
2020 has been a year like no other in recent memory for public health and FDA.
Project Orbis: Strengthening International Collaboration for Oncology Product Reviews, Faster Patient Access to Innovative Therapies
Project Orbis has demonstrated that global regulatory collaboration is attainable and can deliver faster access to new therapies for patients with cancer.
Recently Published Guidances
Jan 05
Mouse Embryo Assay for Assisted Reproduction Technology Devices
Medical Devices
Jan 04
IND Submissions for Individualized Antisense Oligonucleotide Drug Products: Administrative and Procedural Recommendations Guidance for Sponsor-Investigators
Drugs
Dec 30
Consumer Antiseptic Rub Final Rule Questions and Answers Guidance for Industry
Drugs